COVID-19 Human IgG PharmaGenie ELISA Kit (N-Protein) (SBRS1718)

Built for serological research into SARS-CoV-2, this indirect ELISA from Assay Genie detects human IgG antibodies directed against the viral nucleocapsid (N) protein. The kit accepts dried blood spots, plasma, saliva, and serum samples, making it adaptable to field-collected and standard clinical specimens alike. Researchers studying post-infection immunity, vaccine-induced antibody responses, and community-level seroprevalence use this microplate-based assay to profile humoral immune status. The workflow follows standard indirect ELISA methodology, where IgG binding to immobilised N-protein antigen is detected with an enzyme-conjugated secondary antibody. Each kit provides reagents sufficient for 96 assays, supporting moderate-throughput screening. For research use only, the assay is intended for in vitro laboratory work and not for diagnostic decision-making without further validation.